$2.34 Billion is the total value of Artal Group S.A.'s 137 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 22.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | New | SPDR SER TRcall | $396,600,000 | – | 5,000,000 | +100.0% | 16.93% | – |
| LXRX | Buy | LEXICON PHARMACEUTICALS INC | $215,468,000 | +62.8% | 89,778,234 | +26.1% | 9.20% | +30.1% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $92,538,000 | +25.3% | 1,325,000 | +20.5% | 3.95% | +0.1% |
| BGNE | BEIGENE LTDsponsored adr | $87,633,000 | -16.7% | 650,000 | 0.0% | 3.74% | -33.4% | |
| APLS | New | APELLIS PHARMACEUTICALS INC | $68,300,000 | – | 1,000,000 | +100.0% | 2.92% | – |
| BLU | Sell | BELLUS HEALTH INC NEW | $63,360,000 | -2.0% | 6,000,000 | -14.3% | 2.70% | -21.7% |
| MORF | Buy | MORPHIC HLDG INC | $60,845,000 | +69.9% | 2,150,000 | +30.3% | 2.60% | +35.8% |
| SRRK | SCHOLAR ROCK HLDG CORP | $60,638,000 | +26.2% | 8,750,034 | 0.0% | 2.59% | +0.9% | |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $58,584,000 | +164.4% | 2,053,403 | +128.2% | 2.50% | +111.3% |
| FATE | FATE THERAPEUTICS INC | $58,266,000 | -9.6% | 2,600,000 | 0.0% | 2.49% | -27.7% | |
| WW | WW INTL INC | $58,236,000 | -38.5% | 14,818,300 | 0.0% | 2.48% | -50.9% | |
| CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $56,520,000 | +42.5% | 2,000,000 | +33.3% | 2.41% | +13.9% |
| IGMS | Buy | IGM BIOSCIENCES INC | $55,713,000 | +54.5% | 2,450,000 | +22.5% | 2.38% | +23.5% |
| ARGX | Sell | ARGENX SEsponsored adr | $52,958,000 | -65.1% | 150,000 | -62.5% | 2.26% | -72.1% |
| CYTK | Sell | CYTOKINETICS INC | $48,450,000 | -3.3% | 1,000,000 | -21.6% | 2.07% | -22.7% |
| SGEN | Sell | SEAGEN INC | $47,891,000 | -48.4% | 350,000 | -33.3% | 2.04% | -58.8% |
| ALVR | Buy | ALLOVIR INC | $44,004,000 | +385.6% | 5,577,167 | +140.0% | 1.88% | +288.0% |
| FOLD | AMICUS THERAPEUTICS INC | $41,760,000 | -2.8% | 4,000,000 | 0.0% | 1.78% | -22.4% | |
| GOSS | Buy | GOSSAMER BIO INC | $38,895,000 | +97.0% | 3,246,624 | +37.6% | 1.66% | +57.3% |
| SEER | SEER INC | $36,765,000 | -13.5% | 4,750,000 | 0.0% | 1.57% | -30.9% | |
| KRYS | KRYSTAL BIOTECH INC | $34,850,000 | +6.2% | 500,000 | 0.0% | 1.49% | -15.2% | |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $32,655,000 | +65.8% | 1,500,000 | +50.0% | 1.39% | +32.5% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $32,542,000 | +177.5% | 1,454,716 | +107.8% | 1.39% | +121.9% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $29,370,000 | +102.1% | 750,000 | +66.7% | 1.25% | +61.5% |
| KRTX | New | KARUNA THERAPEUTICS INC | $28,116,000 | – | 125,000 | +100.0% | 1.20% | – |
| ERASCA INC | $24,743,000 | +40.0% | 3,172,221 | 0.0% | 1.06% | +11.9% | ||
| Buy | VIGIL NEUROSCIENCE INC | $20,799,000 | +618.9% | 2,285,574 | +103.9% | 0.89% | +472.9% | |
| EQRX INC | $19,800,000 | +5.5% | 4,000,000 | 0.0% | 0.84% | -15.7% | ||
| DNLI | DENALI THERAPEUTICS INC | $18,414,000 | +4.3% | 600,000 | 0.0% | 0.79% | -16.6% | |
| SDGR | SCHRODINGER INC | $17,486,000 | -5.4% | 700,000 | 0.0% | 0.75% | -24.4% | |
| REPL | REPLIMUNE GROUP INC | $15,543,000 | -1.2% | 900,000 | 0.0% | 0.66% | -21.1% | |
| NTLA | INTELLIA THERAPEUTICS INC | $15,389,000 | +8.1% | 275,000 | 0.0% | 0.66% | -13.6% | |
| KURA | Buy | KURA ONCOLOGY INC | $15,026,000 | -21.9% | 1,100,000 | +4.8% | 0.64% | -37.6% |
| GBIO | GENERATION BIO CO | $14,943,000 | -19.1% | 2,814,191 | 0.0% | 0.64% | -35.3% | |
| MRSN | MERSANA THERAPEUTICS INC | $14,872,000 | +46.3% | 2,200,000 | 0.0% | 0.64% | +16.9% | |
| FHTX | FOGHORN THERAPEUTICS INC | $14,764,000 | -36.9% | 1,720,720 | 0.0% | 0.63% | -49.6% | |
| VERV | VERVE THERAPEUTICS INC | $13,740,000 | +124.8% | 400,000 | 0.0% | 0.59% | +79.8% | |
| SGEN | New | SEAGEN INCcall | $13,683,000 | – | 100,000 | +100.0% | 0.58% | – |
| ISEE | New | IVERIC BIO INC | $13,455,000 | – | 750,000 | +100.0% | 0.57% | – |
| OMEGA THERAPEUTICS INC | $12,323,000 | +42.6% | 2,273,530 | 0.0% | 0.53% | +14.1% | ||
| WVE | WAVE LIFE SCIENCES LTD | $10,830,000 | +11.1% | 3,000,000 | 0.0% | 0.46% | -11.3% | |
| EVTCY | EVOTEC AGsponsored ads | $10,103,000 | -26.6% | 1,149,425 | 0.0% | 0.43% | -41.4% | |
| SE | Buy | SEA LTDsponsored ads | $9,669,000 | +151.5% | 172,500 | +200.0% | 0.41% | +101.5% |
| New | SYROS PHARMACEUTICALS INC | $9,427,000 | – | 1,463,829 | +100.0% | 0.40% | – | |
| ISEE | New | IVERIC BIO INCcall | $8,970,000 | – | 500,000 | +100.0% | 0.38% | – |
| ALPN | Buy | ALPINE IMMUNE SCIENCES INC | $8,590,000 | +70.2% | 1,193,030 | +101.2% | 0.37% | +35.9% |
| RPTX | REPARE THERAPEUTICS INC | $8,491,000 | -13.3% | 700,000 | 0.0% | 0.36% | -30.8% | |
| AGEN | Buy | AGENUS INC | $8,200,000 | +40.9% | 4,000,000 | +33.3% | 0.35% | +12.5% |
| SELB | SELECTA BIOSCIENCES INC | $8,008,000 | +25.2% | 4,883,200 | 0.0% | 0.34% | 0.0% | |
| ITOS | ITEOS THERAPEUTICS INC | $7,620,000 | -7.5% | 400,000 | 0.0% | 0.32% | -26.1% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $7,520,000 | -25.2% | 1,000,000 | 0.0% | 0.32% | -40.2% | |
| OMEG | OMEGA ALPHA SPACcl a | $7,448,000 | +0.8% | 750,000 | 0.0% | 0.32% | -19.5% | |
| BGNE | New | BEIGENE LTDcall | $6,741,000 | – | 50,000 | +100.0% | 0.29% | – |
| DYN | DYNE THERAPEUTICS INC | $6,668,000 | +84.9% | 525,000 | 0.0% | 0.28% | +47.7% | |
| YMAB | Y-MABS THERAPEUTICS INC | $5,768,000 | -4.7% | 400,000 | 0.0% | 0.25% | -23.8% | |
| IKNA | IKENA ONCOLOGY INC | $5,501,000 | -19.9% | 1,549,513 | 0.0% | 0.24% | -36.0% | |
| TALS | TALARIS THERAPEUTICS INC | $5,429,000 | -41.7% | 2,064,262 | 0.0% | 0.23% | -53.3% | |
| KRON | KRONOS BIO INC | $5,169,000 | -8.0% | 1,542,954 | 0.0% | 0.22% | -26.3% | |
| LYEL | LYELL IMMUNOPHARMA INC | $5,131,000 | +12.4% | 700,000 | 0.0% | 0.22% | -10.2% | |
| ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $5,097,000 | -10.3% | 2,255,375 | 0.0% | 0.22% | -28.3% | |
| ALXO | ALX ONCOLOGY HLDGS INC | $4,785,000 | +18.3% | 500,000 | 0.0% | 0.20% | -5.6% | |
| RXRX | RECURSION PHARMACEUTICALS INcl a | $4,788,000 | +30.7% | 450,000 | 0.0% | 0.20% | +4.1% | |
| OVID | OVID THERAPEUTICS INC | $4,600,000 | -14.4% | 2,500,000 | 0.0% | 0.20% | -31.7% | |
| EXSCIENTIA PLCads | $4,516,000 | -24.6% | 550,000 | 0.0% | 0.19% | -39.7% | ||
| NTRA | New | NATERA INC | $4,382,000 | – | 100,000 | +100.0% | 0.19% | – |
| RNA | AVIDITY BIOSCIENCES INC | $4,083,000 | +12.4% | 250,000 | 0.0% | 0.17% | -10.3% | |
| OTLY | OATLY GROUP ABsponsored ads | $3,945,000 | -24.0% | 1,500,000 | 0.0% | 0.17% | -39.4% | |
| CNCE | New | CONCERT PHARMACEUTICALS INC | $3,840,000 | – | 573,062 | +100.0% | 0.16% | – |
| New | THIRD HARMONIC BIO INC | $3,794,000 | – | 200,000 | +100.0% | 0.16% | – | |
| MIRION TECHNOLOGIES INC | $3,735,000 | +29.7% | 500,000 | 0.0% | 0.16% | +3.2% | ||
| PORTAGE FINTECH ACQUISITN CO | $3,713,000 | +0.2% | 380,000 | 0.0% | 0.16% | -20.2% | ||
| SQZ | SQZ BIOTECHNOLOGIES CO | $3,662,000 | -28.3% | 1,606,309 | 0.0% | 0.16% | -42.9% | |
| NBTX | NANOBIOTIXsponsored ads | $3,540,000 | -6.8% | 1,000,000 | 0.0% | 0.15% | -25.6% | |
| LPTX | LEAP THERAPEUTICS INC | $3,520,000 | -23.5% | 4,000,000 | 0.0% | 0.15% | -39.0% | |
| IMAB | I MABsponsored ads | $3,409,000 | -64.5% | 850,000 | 0.0% | 0.14% | -71.7% | |
| STOK | STOKE THERAPEUTICS INC | $3,210,000 | -2.8% | 250,000 | 0.0% | 0.14% | -22.2% | |
| CGEM | CULLINAN ONCOLOGY INC | $3,205,000 | 0.0% | 250,000 | 0.0% | 0.14% | -19.9% | |
| ACIU | AC IMMUNE SA | $3,160,000 | -12.5% | 1,000,000 | 0.0% | 0.14% | -30.1% | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $2,783,000 | -31.3% | 1,646,517 | 0.0% | 0.12% | -44.9% | |
| ZYME | ZYMEWORKS INC | $2,768,000 | +16.1% | 450,000 | 0.0% | 0.12% | -7.1% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $2,724,000 | -7.3% | 1,200,000 | 0.0% | 0.12% | -26.1% | |
| BBIO | BRIDGEBIO PHARMA INC | $2,485,000 | +9.5% | 250,000 | 0.0% | 0.11% | -12.4% | |
| HOOK | HOOKIPA PHARMA INC | $2,478,000 | -17.8% | 1,849,616 | 0.0% | 0.11% | -34.2% | |
| CYCN | CYCLERION THERAPEUTICS INC | $2,391,000 | +56.8% | 2,779,122 | 0.0% | 0.10% | +25.9% | |
| SANA | SANA BIOTECHNOLOGY INC | $2,400,000 | -6.7% | 400,000 | 0.0% | 0.10% | -25.5% | |
| AMAM | AMBRX BIOPHARMA INCsponsored ads | $2,324,000 | -59.3% | 2,152,291 | 0.0% | 0.10% | -67.5% | |
| SENTI BIOSCIENCES INC | $2,291,000 | +10.5% | 1,055,555 | 0.0% | 0.10% | -11.7% | ||
| New | MINERVA NEUROSCIENCES INC | $2,308,000 | – | 250,000 | +100.0% | 0.10% | – | |
| FUSN | FUSION PHARMACEUTICALS INC | $2,258,000 | +20.9% | 750,000 | 0.0% | 0.10% | -4.0% | |
| APTX | APTINYX INC | $2,251,000 | -34.0% | 6,116,493 | 0.0% | 0.10% | -47.3% | |
| GRPH | GRAPHITE BIO INC | $2,219,000 | +15.3% | 700,000 | 0.0% | 0.10% | -7.8% | |
| IMUX | IMMUNIC INC | $2,212,000 | -8.9% | 700,000 | 0.0% | 0.09% | -27.7% | |
| TIL | INSTIL BIO INC | $2,178,000 | +4.8% | 450,000 | 0.0% | 0.09% | -16.2% | |
| VOR | VOR BIOPHARMA INC | $2,189,000 | -19.9% | 550,000 | 0.0% | 0.09% | -36.3% | |
| TSHA | TAYSHA GENE THERAPIES INC | $2,009,000 | -48.1% | 1,040,882 | 0.0% | 0.09% | -58.5% | |
| GRTS | GRITSTONE BIO INC | $1,928,000 | +6.2% | 750,000 | 0.0% | 0.08% | -15.5% | |
| ME | 23ANDME HOLDING CO | $1,890,000 | +15.3% | 661,009 | 0.0% | 0.08% | -8.0% | |
| YI | Sell | 111 INCads | $1,840,000 | -7.6% | 686,431 | -29.0% | 0.08% | -25.5% |
| IMMP | IMMUTEP LTDsponsored ads | $1,560,000 | -23.2% | 1,000,000 | 0.0% | 0.07% | -38.0% | |
| KNTE | KINNATE BIOPHARMA INC | $1,494,000 | -5.2% | 125,000 | 0.0% | 0.06% | -23.8% | |
| SLDB | SOLID BIOSCIENCES INC | $1,400,000 | -24.2% | 3,000,000 | 0.0% | 0.06% | -39.4% | |
| TCRR | TCR2 THERAPEUTICS INC | $1,350,000 | -37.9% | 750,000 | 0.0% | 0.06% | -50.0% | |
| XILIO THERAPEUTICS INC | $1,310,000 | -0.3% | 450,000 | 0.0% | 0.06% | -20.0% | ||
| MREO | MEREO BIOPHARMA GROUP PLCspon ads | $1,292,000 | -23.1% | 1,500,000 | 0.0% | 0.06% | -38.9% | |
| ADAG | ADAGENE INCads | $1,280,000 | -38.0% | 1,000,000 | 0.0% | 0.06% | -50.0% | |
| ORIC | ORIC PHARMACEUTICALS INC | $1,280,000 | -28.6% | 400,000 | 0.0% | 0.06% | -42.7% | |
| AXLA | AXCELLA HEALTH INC | $1,218,000 | -15.8% | 712,500 | 0.0% | 0.05% | -32.5% | |
| IGMS | IGM BIOSCIENCES INCcall | $1,137,000 | +26.1% | 50,000 | 0.0% | 0.05% | +2.1% | |
| CRDF | CARDIFF ONCOLOGY INC | $1,155,000 | -30.0% | 750,000 | 0.0% | 0.05% | -44.3% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $1,145,000 | -10.1% | 110,532 | 0.0% | 0.05% | -27.9% | |
| CARIBOU BIOSCIENCES INC | $1,111,000 | +94.2% | 105,347 | 0.0% | 0.05% | +51.6% | ||
| ARAV | ARAVIVE INC | $1,072,000 | -17.2% | 1,311,291 | 0.0% | 0.05% | -33.3% | |
| Sell | MARINUS PHARMACEUTICALS INC | $1,044,000 | -78.4% | 157,000 | -84.3% | 0.04% | -82.6% | |
| SPRO | SPERO THERAPEUTICS INC | $1,000,000 | +169.5% | 500,000 | 0.0% | 0.04% | +115.0% | |
| HARP | HARPOON THERAPEUTICS INC | $970,000 | -49.2% | 1,000,000 | 0.0% | 0.04% | -59.8% | |
| CRIS | CURIS INC | $910,000 | -28.9% | 1,300,000 | 0.0% | 0.04% | -42.6% | |
| LVTX | LAVA THERAPEUTICS NV | $914,000 | +54.9% | 200,000 | 0.0% | 0.04% | +21.9% | |
| RUBY | Sell | RUBIUS THERAPEUTICS INC | $886,000 | -71.9% | 2,042,666 | -44.8% | 0.04% | -77.4% |
| AVTR | New | AVANTOR INC | $882,000 | – | 45,000 | +100.0% | 0.04% | – |
| ORTX | ORCHARD THERAPEUTICS PLCspon ads | $902,000 | -14.4% | 1,803,858 | 0.0% | 0.04% | -32.1% | |
| OLMA | OLEMA PHARMACEUTICALS INC | $719,000 | -32.2% | 260,500 | 0.0% | 0.03% | -45.6% | |
| NEXI | NEXIMMUNE INC | $666,000 | -65.5% | 1,200,000 | 0.0% | 0.03% | -72.8% | |
| MINK THERAPEUTICS INC | $611,000 | +49.8% | 289,588 | 0.0% | 0.03% | +18.2% | ||
| MTCR | METACRINE INC | $449,000 | -2.8% | 924,898 | 0.0% | 0.02% | -24.0% | |
| New | HIPPO HLDGS INC | $445,000 | – | 24,000 | +100.0% | 0.02% | – | |
| MEIP | MEI PHARMA INC | $387,000 | -36.0% | 1,000,000 | 0.0% | 0.02% | -46.9% | |
| CRVS | CORVUS PHARMACEUTICALS INC | $409,000 | -17.4% | 500,000 | 0.0% | 0.02% | -34.6% | |
| APLT | APPLIED THERAPEUTICS INC | $372,000 | -1.8% | 400,000 | 0.0% | 0.02% | -20.0% | |
| YMTX | YUMANITY THERAPEUTICS INC | $341,000 | -13.9% | 217,391 | 0.0% | 0.02% | -28.6% | |
| ADBE | New | ADOBE SYSTEMS INCORPORATED | $358,000 | – | 1,300 | +100.0% | 0.02% | – |
| ASTRIA THERAPEUTICS INC | $301,000 | +201.0% | 33,333 | 0.0% | 0.01% | +160.0% | ||
| CFRX | CONTRAFECT CORP | $252,000 | -94.5% | 1,500,000 | 0.0% | 0.01% | -95.5% | |
| CDAK | CODIAK BIOSCIENCES INC | $156,000 | -72.9% | 200,000 | 0.0% | 0.01% | -77.4% | |
| SGTX | SIGILON THERAPEUTICS INC | $139,000 | -39.3% | 276,000 | 0.0% | 0.01% | -50.0% | |
| CDTX | CIDARA THERAPEUTICS INC | $141,000 | +28.2% | 224,675 | 0.0% | 0.01% | 0.0% | |
| KLDO | Exit | KALEIDO BIOSCIENCES INC | $0 | – | -500,500 | -100.0% | -0.00% | – |
| Exit | BATH & BODY WORKS INC | $0 | – | -12,500 | -100.0% | -0.02% | – | |
| UNG | Exit | UNITED STS NAT GAS FD LPunit par | $0 | – | -20,000 | -100.0% | -0.02% | – |
| CLF | Exit | CLEVELAND-CLIFFS INC NEW | $0 | – | -25,000 | -100.0% | -0.02% | – |
| Exit | HIPPO HLDGS INC | $0 | – | -600,000 | -100.0% | -0.03% | – | |
| Exit | AMYLYX PHARMACEUTICALS INC | $0 | – | -75,000 | -100.0% | -0.08% | – | |
| Exit | CINCOR PHARMA INC | $0 | – | -137,010 | -100.0% | -0.14% | – | |
| Exit | ADAGIO THERAPEUTICS INC | $0 | – | -1,000,000 | -100.0% | -0.18% | – | |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -3,000,000 | -100.0% | -0.19% | – |
| SYRS | Exit | SYROS PHARMACEUTICALS INC | $0 | – | -4,000,000 | -100.0% | -0.21% | – |
| DSGN | Exit | DESIGN THERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -0.30% | – |
| ATRA | Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -1,000,000 | -100.0% | -0.42% | – |
| LABU | Exit | DIREXION SHS ETF TRcall | $0 | – | -4,000,000 | -100.0% | -1.44% | – |
| C | Exit | CITIGROUP INCcall | $0 | – | -1,000,000 | -100.0% | -2.46% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -600,000 | -100.0% | -4.67% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.